Concepedia

Ling Li

LL

Statistics

Publications

69

Citations

2.7K

H-Index

30

Active since

2012

Affiliations

First Affiliated Hospital of Zhengzhou University(Current)

Zhengzhou University

The University of Texas MD Anderson Cancer Center

Cleveland Clinic Lerner College of Medicine

Central South University

Ling Li is an author at First Affiliated Hospital of Zhengzhou University specializing in oncology, medicine, and molecular oncology.

Publications per year

2012–2025

69

Publications

69

Activity of pembrolizumab in relapsed/refractory NK/T-cell lymphoma

Xin Li, Mingzhi Zhang, Jiaqin Yan et al. · Journal of Hematology & Oncology · 2018 · 197 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Antibody Against CD44s Inhibits Pancreatic Tumor Initiation and Postradiation Recurrence in Mice

Ling Li, Xinbao Hao, Jun Qin et al. · Gastroenterology · 2014 · 163 citations · Full text

Medicine, Oncology, Radiation Oncology +12

miR-153 suppresses IDO1 expression and enhances CAR T cell immunotherapy

Qian Huang, Jiajia Xia, Lei Wang et al. · Journal of Hematology & Oncology · 2018 · 134 citations · Full text

Life Sciences, Immunology, Oncology +17

miR-21 depletion in macrophages promotes tumoricidal polarization and enhances PD-1 immunotherapy

Jiajia Xi, Qian Huang, Lei Wang et al. · Oncogene · 2018 · 127 citations · Full text

Life Sciences, Immunology, Oncology +15

Autologous Nanobody-Derived Fratricide-Resistant CD7-CAR T-cell Therapy for Patients with Relapsed and Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma

Mingzhi Zhang, Dan Chen, Xiaorui Fu et al. · Clinical Cancer Research · 2022 · 113 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 69